Virologic Failure and Human Immunodeficiency Virus Drug Resistance in Rural Cameroon With Regard to the UNAIDS 90-90-90 Treatment Targets
Author(s) -
Charlotte Boullé,
Emilande Guichet,
Charles Kouanfack,
Avelin F. Aghokeng,
Benjamin Onambany,
Catherine Massama Ikaka,
Emile Ngock,
Landry Tsoumsta,
Philippe Msellati,
Eitel MpoudiNgolé,
Martine Peeters,
Éric Delaporte,
Christian Laurent
Publication year - 2016
Publication title -
open forum infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.546
H-Index - 35
ISSN - 2328-8957
DOI - 10.1093/ofid/ofw233
Subject(s) - medicine , viral load , hiv drug resistance , drug resistance , confidence interval , logistic regression , reverse transcriptase , virology , cross sectional study , reverse transcriptase inhibitor , antiretroviral therapy , immunology , human immunodeficiency virus (hiv) , polymerase chain reaction , biology , pathology , biochemistry , gene , microbiology and biotechnology
Our estimations were among the highest observed in the west and central African region. The proportion of patients with virologic failure should be divided at least by 2 to reach the UNAIDS 90-90-90 treatment targets.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom